Sophia Hober, PhD

Professor and Principal Investigator at KTH Royal Institute of Technology

Speaker

Sophia Hober is Professor of Molecular Biotechnology at KTH in Stockholm, Sweden. She is working with the design and development of detection and purification systems including improvements of the alkaline tolerance of protein A for industrial purification of IgG, leading to a product sold by Cytiva (MabSelect SuRe). Moreover, two novel libraries with different characteristics have been designed based on small scaffold proteins. These are utilized for development of binders for use in protein purification as well as for cancer theranostics. Prof. Hober is the author of more than 190 full‑length scientific papers and has filed more than 20 international patent applications. Prof. Hober is cofounder of 4 start-up companies and member of several Board of Directors. She is also elected member of the Royal Swedish Academy of Engineering Sciences.